RXO, Inc.
NYSE:RXOTrucking
+$0.80 today
- Market cap
- $4.72B
- Beta
- 1.97
- P/E (TTM)
- -41.3
- EPS (TTM)
- -$0.62
Volume 3.64M
Average 2.33M
RXO Total Liabilities
Everything the company owes to creditors and other parties.
RXO, Inc.NYSE: RXO
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities falls 99.9% from a year ago
Total liabilities stood at $1.95M at the end of Q2 FY2026, down 99.9% from a year earlier and down 99.9% from the prior quarter. Over 3 fiscal years it compounded at +6.3% a year.
Context
- Total liabilities amounted to 56.5% of total assets at the end of Q2 FY2026, up 6.1 pp from a year earlier.
- Total liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -99.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 1.74B USD
- Year-over-year change
- -3.7%
- 4-year CAGR
- +14.8%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.74B | -3.7% |
| FY2024 | 2024-12-31 | 1.8B | +46.4% |
| FY2023 | 2023-12-31 | 1.23B | -14.8% |
| FY2022 | 2022-12-31 | 1.44B | +44.7% |
| FY2021 | 2021-12-31 | 998M | — |
Total Liabilities vs competitors
How RXO compares with its peers on the latest reported figures
- RXO's Jun 2026 total liabilities of $1.95M is the lowest of the 11 companies compared; the peer median is $1.63B.
- Its year-over-year change of -99.9% is the lowest of 11, against a peer median of +7.1%.
- Total liabilities amounts to 56.5% of total assets for RXO, versus a peer median of 52.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $4.09B | +3.8% | +18.5% | 91.0% | |
| Jul 2026 | $3.81B | +10.8% | +5.3% | 68.0% | |
| Jun 2026 | $2.93B | +6.2% | -2.1% | 60.2% | |
TICTIC Solutions, Inc. | Jun 2026 | $2.2B | +106.5% | — | 51.2% |
| Jun 2026 | $1.94B | +4.1% | -0.5% | 41.2% | |
| Jun 2026 | $1.31B | -4.4% | -8.7% | 33.1% | |
| Jun 2026 | $1.26B | +8.1% | +7.4% | 50.2% | |
| Sep 2026 | $1.21B | +137.2% | +64.4% | 54.1% | |
| Mar 2026 | $878.58M | +60.0% | +35.8% | 99.2% | |
| Mar 2026 | $21.37M | -55.5% | +73.6% | 16.3% | |
| Jun 2026 | $1.95M | -99.9% | +6.3% | 56.5% | |
| Peer median (excluding RXO) | $1.63B | +7.1% | +7.4% | 52.6% | |
Competitors are the stored peer set for RXO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
RXO, Inc.
NYSE:RXO
Intrinsic Alpha fair value
Locked
Current Price
$28.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.